Simple, supply and demand. Plenty of biology students and not enough growth in the industry. Biotech and healthcare have a ton of regulatory capture, gatekeepin

Simple, supply and demand. Plenty of biology students and not enough growth in the industry. Biotech and healthcare have a ton of regulatory capture, gatekeeping, and barriers of entry that you do not really have any good companies to choose from. Other than your traditional pharma giants, there are not many alternatives. Theranos was supposed to be biology's Google, its unicorn trailblazer. Unfortunately it did not work out. YC's Gingko looks good on paper but it is no exponential growth machine.